Chicago Equity Partners’s BioTelemetry, Inc. BEAT Stock Holding History

Chicago Equity Partners’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-13,855	Closed	-$667K	–	1025
2019 Q2	$667K	Hold	13,855	–	–	0.03%	637
2019 Q1	$868K	Sell	13,855 -7,615	-35%	-$523K	0.03%	546
2018 Q4	$1.28M	Hold	21,470	–	–	0.05%	438
2018 Q3	$1.38M	Buy	+21,470	New	+$1.2M	0.04%	460

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCAMU

Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Chicago Equity Partners's BEAT Position: Q3 2019 in Review

Chicago Equity Partners sold out of BioTelemetry, Inc. (BEAT) in Q3 2019, closing a stake of 13,855 shares — an estimated $667K sold.

Chicago Equity Partners first reported a position in BEAT in Q3 2018 and held it in 4 quarters. The position peaked at $1.38M in Q3 2018. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

Chicago Equity Partners reported no remaining BioTelemetry, Inc. position as of Q3 2019 after selling out during the quarter.
Chicago Equity Partners sold 13,855 BioTelemetry, Inc. shares in Q3 2019, an estimated $667K.
Chicago Equity Partners first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 4 quarters.
Chicago Equity Partners's BioTelemetry, Inc. position peaked at $1.38M in Q3 2018.
219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Chicago Equity Partners's 13F filing for Q3 2019, filed 30 Oct 2019.